Search Results

Exploring the Hidden Dynamics: How Kinetics Reveals What Equilibrium Conceals in GPCR Research. Hi GPCR Community, If equilibrium curves are your comfort zone, this week’s feature will challenge (and GPCR Premium: Sneak Peek Here’s a fast, high-level preview of what Premium Members are unpacking this We’ve got your GPCR Track, Happy Hour, and sessions mapped so you can extract maximum value. GPCR innovation is accelerating.

Exploring the intracellular allosteric site GPCRs represent one of the largest and most vital families For this reason, GPCRs have been a focus of drug development for decades due to their role in regulating Conventional GPCR drug discovery has largely focused on orthosteric sites, but recent breakthroughs in GPCR activity, enabling greater specificity and fewer side effects. allosteric site common in class A and class B GPCRs, particularly in chemokine receptors.

For decades, GPCRs have been the cornerstone of pharmacology. GPCR Modeling in Context: Then and Now When Carlsson entered the GPCR field in the early 2000s, structural Why Predictive GPCR Modeling Matters Now The convergence of machine learning, improved GPCR structures Want to go deeper into GPCR modeling? Dr. GPCR Podcast Push the boundaries of what's possible 👉 Join the Dr.

, is harder than orthosteric small-molecule programs at smaller receptors have led the field to expect model among several, but it explains the observation cleanly, and it has practical consequences for how programs What GPCR Biologic Drugs Reveal About the Active-State Problem Family B GPCRs are conformationally malleable What This Means for Program Decisions The affinity-trap account, treated as a model rather than a verdict It suggests that the difficulty an orthosteric small-molecule agonist program encounters at a family

Terry's Corner – Designing Drugs That Anticipate Physiological Pushback Most GPCR programs don’t fail GPCR , our mission is simple but urgent: Accelerate GPCR biology and drug discovery by connecting scientists GPCR Podcast, the Revvity team built pHSense™ from the ground up by listening to what GPCR scientists GPCR innovation is accelerating. GPCR and the offered resources in my work sphere." — DrGPCR University Attendee GPCR innovation doesn

2026 GPCR Pharmacology AMA: Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology as new videos are released: ▶️ https://www.youtube.com/@TerryPharmacologyCorner New White Paper on GPCR School of Medicine, has authored a new white paper in collaboration with Eurofins DiscoverX: Assess GPCR programs, this connects functional assay data directly to translational decision-making — moving beyond theory and mechanistic reasoning The value lies not in a single explanation, but in preserving rigor as programs

Welcome back GPCR fans, If your drug discovery strategy still relies on static GPCR models, you’re already Upcoming events:  GPCR-UK Network Meeting, neuroGPCR symposium, and Transatlantic ECI GPCR event—where GPCR Podcast Listener Why Dr. GPCR Premium 🔹 What’s included? The pace of GPCR innovation is accelerating.

infrastructure, not duplicated equipment Centralized core facilities for receptor assays PhD students trained across multiple techniques, not just one pipeline Senior scientists embedded as “connectors” between programs The structure you train in often matters more than the experiment you start with. Year 2  — Core imaging and signaling platforms launched Year 4  — Pooled grants fund expansion and training programs Year 7  — International collaborations and industry partnerships take root Today  — Model continues

In GPCR drug discovery, a single mistaken assumption can derail an entire program. Why Misreading Antagonism Delays GPCR Drug Discovery If a dose-response curve shifts to the right, you Why now:  GPCR research is accelerating—and the projects that succeed will be those built on clear, accurate This is the kind of insight that makes the difference between a dead-end program and a well-informed

GPCR research requires turning data into insights for drug discovery Hi GPCR Friends, Every week, critical decisions in GPCR research hinge on subtle shifts in data. GPCR Podcast – Ajay Yekkirala on GPCR Innovation In this episode, Dr. of scientists, leaders, and investors ready to compare notes, spark collaborations, and accelerate programs The pace of GPCR innovation is accelerating.

GPCR podcast is now available! Our guest is Mark Schmeizl! Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast

Read more at the source #DrGPCR #GPCR #IndustryNews

That’s not a story about nostalgia — it’s a snapshot of how GPCR research was built, on technique at The Era of Cold Fingers and Patience Back then, GPCR signaling experiments weren’t elegant; they were Every step felt like it could make or break the result, The pace and precision of GPCR research today The GPCR field needs thinkers who can direct platforms, not just operate them. GPCR Podcast 🔓 Get tools, deep dives, and exclusive insights with   Dr. GPCR Premium .

GPCR Ecosystem paid membership with extra benefits? 🔬Join the #GPCR movement today! ➡️ https://www.ecosystem.drgpcr.com/plans-pricing #gpcr #drgpcr

📰 GPCR Weekly News, July 8 to 14, 2024 Hello readers! Check out our GPCR coverage for this week. Target Program aimed at discovering new drugs. GPCR Event Highlight 11th Adhesion GPCR Workshop Hosted by the Adhesion GPCR Consortium, this event will Biotherapeutics Post-Doctoral Fellow/Trainee Scientist; Biochemistry, Cellular and Mechanistic Pharmacology GPCR Ecosystem

August 2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third Read more at the source #DrGPCR #GPCR #IndustryNews

of how residence time—not potency—predicts therapeutic coverage ✅ Insight into cryptic intracellular GPCR evaluating scaffold permeability using modern, cost-effective pharmacokinetic assays   Why Intracellular GPCR Drugs Change the Game For decades, drug design has treated GPCRs as surface targets. You’ll learn how to recognize and harness this in your own programs.   GPCRs now have validated intracellular  allosteric sites.

GPCR. of GPCR research and drug discovery. Why contribute: Join a global, like-minded GPCR community. The pace of GPCR innovation is accelerating. community platform to help train and inspire the next generation of scientists.” — Dr.

GPCR activation typically occurs through the binding of agonists which stabilize receptor conformations GPCR targeting drugs: orthosteric vs allosteric sites Most of the drugs targeting GPCRs bind to the orthosteric GPCRs functional selectivity Recent research has revealed a more intricate understanding of GPCR behavior Agonist binding to GPCRs doesn't always trigger all associated events sequentially. selectively activate specific cellular outcomes linked to that GPCR.

GPCR podcast is now available! Our guest is Dr. Adriano Marchese! Learn about his remarkable career and research in #GPCR signaling and trafficking. Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast

August 2022 "The common mechanisms by which members of the G protein-coupled receptor (GPCR) family respond to neurotransmitters in the brain have been well studied. Here we will discuss recent studies on the diversity of location, effectors, and signaling of GPCRs, and how these could interact to generate specific spatiotemporal patterns of GPCR signaling in cells. Read more at the source #DrGPCR #GPCR #IndustryNews

Rho1 signaling is activated by G-protein-coupled receptor (GPCR) signaling at the cell surface. During Drosophila embryonic salivary gland (SG) invagination, the GPCR ligand Folded gastrulation (Fog Here, we reveal that the Smog GPCR transduces Fog signal to regulate Rho kinase accumulation and myosin Read more at the source #DrGPCR #GPCR #IndustryNews

Join us and learn how to quantify your kinetic GPCR signaling from the expert himself: Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

May 2022 "Seoul, South Korea, 28 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR GPCR just had a very successful first meeting including all the Scientific Advisory Board." Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Ecosystem with a paid membership for extra benefits. Catch up with the latest #GPCR news, our monthly Virtual Cafe, and much more! Join the #GPCR movement today! ➡️ https://bit.ly/3SUkB8D

In order to expand its role in GPCRs, which antibodies tend to have more trouble binding to. How Fluorescent Ligands Transform Flow Cytometry in GPCR Analysis GPCRs are a tough target in traditional ligands provide new capabilities: -            Real time tracking they allow continuous observation of GPCR conjunction with fluorescent tags to study biased signaling pathways, improving our understanding of GPCR Illuminating the life of GPCRs.

GPCR podcast is now available! Our guest is Dr. Mark Connor! Learn more about #GPCRs and life as an academic wearing different hats. Listen nowhere you get your podcasts. https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #gpcr #drgpcr

GPCR Podcast, we have none other than Dr. Marta Filizola! https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #gpcr #drgpcr #podcast

Rho1 signaling is activated by G-protein-coupled receptor (GPCR) signaling at the cell surface. During Drosophila embryonic salivary gland (SG) invagination, the GPCR ligand Folded gastrulation (Fog Here, we reveal that the Smog GPCR transduces Fog signal to regulate Rho kinase accumulation and myosin Read more at the source #DrGPCR #GPCR #IndustryNews

Did you know that each month we collect the most recent #GPCR publications and the newest Biotech/Pharma GPCR-related news? GPCR monthly newsletter for FREE! ➡️ https://bit.ly/3cCI4em #gpcr #drgpcr